๎๊ฒ์
๎๊ฒ์
๎
Tvardi Therapeutics Ord Shs
TVRD๎ญ๊ด์ฌ ๋ชฉ๋ก์ ์ถ๊ฐ
3.970USD
+0.010+0.25%
์์ฅ ์ด์ ์๊ฐย ๏ผET๏ผ์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
37.24M์๊ฐ์ด์ก
0.61P/E TTM
๎
์์ธํ ๋ด์ฉ์ ํ์ฌ
Tvardi Therapeutics Ord Shs ์ ๋ณด
๎์ข
๋ชฉ ์ฝ๋ - -
ํ์ฌ ์ด๋ฆ- -
์์ฅ์ผ- -
CEO- -
์ง์ ์- -
์ ํ- -
ํ๊ณ ์ฐ๋ ์ข
๋ฃ- -
์ฃผ์- -
๋์- -
์ฆ๊ถ ๊ฑฐ๋์- -
๊ตญ๊ฐ- -
์ฐํธ ๋ฒํธ- -
์ ํ- -
์น์ฌ์ดํธ- -
์ข
๋ชฉ ์ฝ๋ - -
์์ฅ์ผ- -
CEO- -
Tvardi Therapeutics Ord Shs์ ํ์ฌ ์์์ง
๎์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Dr. Susan Shiff, Ph.D.
Dr. Susan Shiff, Ph.D.
Independent Director
Independent Director
5.61K
--
Mr. Sujal A. Shah
Mr. Sujal A. Shah
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Wallace Hall
Mr. Wallace Hall
Independent Director
Independent Director
--
--
Mr. Michael S. Wyzga
Mr. Michael S. Wyzga
Independent Director
Independent Director
--
--
Dr. Imran Alibhai, Ph.D.
Dr. Imran Alibhai, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
--
--
Mr. Dan Conn, J.D.
Mr. Dan Conn, J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. John Kauh, M.D.
Dr. John Kauh, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Jeffrey (Jeff) Larson, Ph.D.
Dr. Jeffrey (Jeff) Larson, Ph.D.
Senior Vice President - Research & Development
Senior Vice President - Research & Development
--
--
Dr. Yixin (Joseph) Chen, Ph.D.
Dr. Yixin (Joseph) Chen, Ph.D.
Vice President - Chemistry, Manufacturing and Controls
Vice President - Chemistry, Manufacturing and Controls
--
--
๋ ๋ณด๊ธฐ
์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Dr. Susan Shiff, Ph.D.
Dr. Susan Shiff, Ph.D.
Independent Director
Independent Director
5.61K
--
Mr. Sujal A. Shah
Mr. Sujal A. Shah
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Wallace Hall
Mr. Wallace Hall
Independent Director
Independent Director
--
--
Mr. Michael S. Wyzga
Mr. Michael S. Wyzga
Independent Director
Independent Director
--
--
Dr. Imran Alibhai, Ph.D.
Dr. Imran Alibhai, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
--
--
์์ต ๋ถ์
ํตํ: USD๋ง์ง๋ง ์
๋ฐ์ดํธ: Tue, Dec 9
ํตํ: USD๋ง์ง๋ง ์
๋ฐ์ดํธ: Tue, Dec 9
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q3
FY2023Q2
FY2023Q1
FY2021
์ฌ์
๋ณUSD
์ด๋ฆ
์์ต
๋น์จ
Other revenue
1.32M
51.50%
Collaborative revenue
1.20M
46.63%
Clinical compound revenue
48.00K
1.87%
Commercial supply revenue
0.00
0.00%
์ง์ญ๋ณUSD
์ด๋ฆ
์์ต
๋น์จ
United States
0.00
0.00%
์ฌ์
๋ณ
์ง์ญ๋ณ
์ฌ์
๋ณUSD
์ด๋ฆ
์์ต
๋น์จ
Other revenue
1.32M
51.50%
Collaborative revenue
1.20M
46.63%
Clinical compound revenue
48.00K
1.87%
Commercial supply revenue
0.00
0.00%
์ฃผ์ ๋ณด์ ํต๊ณ
๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, May 14
๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, May 14
์ฃผ์ฃผ
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Sporos Bioventures LLC
8.93%
Solas Tvardi Sidecar LLC
8.11%
Slate Path Capital LP
7.51%
Tweardy (David John)
6.92%
DePinho (Ronald A)
4.54%
๊ธฐํ
63.99%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Sporos Bioventures LLC
8.93%
Solas Tvardi Sidecar LLC
8.11%
Slate Path Capital LP
7.51%
Tweardy (David John)
6.92%
DePinho (Ronald A)
4.54%
๊ธฐํ
63.99%
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
๋น์จ
Corporation
19.23%
Individual Investor
15.41%
Investment Advisor
10.61%
Hedge Fund
9.44%
Investment Advisor/Hedge Fund
5.53%
Insurance Company
2.38%
Research Firm
1.95%
Venture Capital
0.14%
Bank and Trust
0.09%
๊ธฐํ
35.23%
๊ธฐ๊ด ์ฃผ์ ๋ณด์
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Apr 1
๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Apr 1
๋ณด๊ณ ๊ธฐ๊ฐ
๊ธฐ๊ด ์
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
2026Q4
126
2.64M
22.11%
--
2026Q1
204
3.26M
34.71%
+227.27K
2025Q4
205
2.69M
28.71%
+324.75K
2025Q3
240
2.63M
28.09%
+211.56K
2025Q2
255
1.96M
20.86%
+381.35K
2025Q1
304
216.78K
14.22%
-690.19K
2024Q4
335
370.98K
24.35%
-475.57K
2024Q3
349
383.52K
25.18%
-554.07K
2024Q2
363
500.51K
32.96%
-507.31K
2024Q1
376
666.56K
43.91%
-330.38K
๋ ๋ณด๊ธฐ
์ฃผ์ฃผ ํ๋
๎์ด๋ฆ
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
Chg %
๋ ์ง
Sporos Bioventures LLC
837.64K
8.93%
--
--
Oct 20, 2025
Solas Tvardi Sidecar LLC
761.29K
8.11%
--
--
Oct 20, 2025
Slate Path Capital LP
704.12K
7.51%
--
--
Dec 31, 2025
Tweardy (David John)
649.05K
6.92%
--
--
Oct 20, 2025
DePinho (Ronald A)
426.19K
4.54%
-200.00K
-31.94%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
367.68K
3.92%
+61.74K
+20.18%
Dec 31, 2025
Tweardy (Samuel David)
315.66K
3.36%
-631.32K
-66.67%
Jul 07, 2025
American Financial Group, Inc.
223.66K
2.38%
+223.66K
--
Dec 31, 2025
Vifor (International), Ltd
205.47K
2.19%
-1.00
-0.00%
Apr 16, 2025
๋ ๋ณด๊ธฐ
๊ด๋ จ ETF
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Tue, Dec 9
๋ง์ง๋ง ์
๋ฐ์ดํธ: Tue, Dec 9
์ด๋ฆ
๋น์จ
Invesco Dorsey Wright SmallCap Momentum ETF
0.04%
Texas Capital Texas Small Cap Equity Index ETF
0.01%
iShares Russell 2000 ETF
0%
Fidelity Enhanced Small Cap ETF
0%
iShares Russell 2000 Growth ETF
0%
Amplify Seymour Cannabis ETF
0%
iShares Russell 3000 ETF
0%
Global X Russell 2000 ETF
0%
Schwab U.S. Small-Cap ETF
0%
ProShares UltraPro Russell2000
0%
๋ ๋ณด๊ธฐ
Invesco Dorsey Wright SmallCap Momentum ETF
๋น์จ0.04%
Texas Capital Texas Small Cap Equity Index ETF
๋น์จ0.01%
iShares Russell 2000 ETF
๋น์จ0%
Fidelity Enhanced Small Cap ETF
๋น์จ0%
iShares Russell 2000 Growth ETF
๋น์จ0%
Amplify Seymour Cannabis ETF
๋น์จ0%
iShares Russell 3000 ETF
๋น์จ0%
Global X Russell 2000 ETF
๋น์จ0%
Schwab U.S. Small-Cap ETF
๋น์จ0%
ProShares UltraPro Russell2000
๋น์จ0%
์ฃผ์ ๋ฐฐ๋น๊ธ
๎์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.
๋ ์ง
๋ฐฐ๋น๊ธ
๊ธฐ์ค์ผ
์ง๊ธ์ผ
๋ฐฐ๋น๋ฝ์ผ
๋ฐ์ดํฐ ์์
์ฃผ์ ๋ถํ
๎๋ ์ง
๋ฐฐ๋น๋ฝ์ผ
์ ํ
๋น์จ
Apr 14, 2025
Merger
3โ1
๋ ์ง
๋ฐฐ๋น๋ฝ์ผ
์ ํ
๋น์จ
Apr 14, 2025
Merger
3โ1
